Contract research, development, and manufacturing services for global pharma
WuXi AppTec operates a large-scale CRDMO platform spanning R&D and manufacturing across Asia, Europe, and North America. The tech stack reflects heavy operational maturity—SAP S/4HANA, Maximo, MES, LIMS (Labware), and process-control systems (Aveva PI, Kepware)—combined with active migration toward Oracle and deeper SAP adoption. Hiring velocity is accelerating across manufacturing, research, and engineering roles, while active projects cluster around compliance, validation, and sterile manufacturing—signaling either recent regulatory audits or scaling into new GMP-certified facilities.
Notable leadership hires: Quality Control Director, Director of Engineering, Business Development Head, Marketing Director, Sterile Engineering Lead
WuXi AppTec is a publicly traded CRDMO operating across 30+ countries and serving nearly 6,000 pharmaceutical and life-sciences partners. The company provides integrated end-to-end services spanning drug discovery, API development, biologics manufacturing, and clinical/regulatory support. Operations are anchored in Shanghai with regional hubs in the US, Europe, and Asia, supported by ERP, laboratory information systems, and manufacturing execution platforms. Current organizational scale (10,001+ employees) reflects the capital and labor intensity of pharma manufacturing and the breadth of regulated service lines.
Primary stack: SAP S/4HANA, IBM Maximo, MES, and Labware LIMS for lab management. Also deployed: Aveva PI for process control, Kepware for equipment integration, and Waters Empower for chromatography. Currently adopting Oracle alongside expanded SAP footprint.
Headquarters in Shanghai. Active hiring in United States, Switzerland, China, Belgium, and Germany. Serves partners across 30+ countries with regional operations spanning Asia, Europe, and North America.
Other companies in the same industry, closest in size